Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kanebratt KP"'
Autor:
Kanebratt, KP, Diczfalusy, U, Bäckström, T, Sparve, E, Bredberg, E, Böttiger, Y, Andersson, TB, Bertilsson, L
Publikováno v:
Clinical Pharmacology & Therapeutics; Nov2008, Vol. 84 Issue 5, p589-594, 6p, 1 Chart, 3 Graphs
Autor:
Arjmandi H; Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden., Vilén L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Noel A; School of Engineering, University of Warwick, Coventry, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2024 Sep 12; Vol. 19 (9), pp. e0310109. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
Rigal S; TissUse GmbH, Berlin, Germany., Casas B; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wennberg Huldt C; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Magnusson LU; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Müllers E; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Karlsson F; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Clausen M; Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Hansson SF; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Leonard L; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Cairns J; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Jansson Löfmark R; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ämmälä C; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Cedersund G; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden., Andersson TB; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Vilén LK; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. liisa.vilen@astrazeneca.com.; Division of Pharmaceutical Biosciences, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. liisa.vilen@astrazeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2024 Jul 18; Vol. 7 (1), pp. 877. Date of Electronic Publication: 2024 Jul 18.
Autor:
Casas B; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Vilén L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bauer S; TissUse GmbH, Berlin, Germany., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wennberg Huldt C; Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Magnusson L; Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Andersson TB; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Cedersund G; Department of Biomedical Engineering, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2022 Oct 19; Vol. 18 (10), pp. e1010587. Date of Electronic Publication: 2022 Oct 19 (Print Publication: 2022).
Autor:
Kanebratt KP; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden. Electronic address: kajsa.p.kanebratt@astrazeneca.com., Janefeldt A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Vilén L; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Vildhede A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Samuelsson K; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Milton L; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Björkbom A; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Persson M; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Leandersson C; Physical & Analytical Chemistry, Research and Early Development Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Andersson TB; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden., Hilgendorf C; DMPK, Research and Early Development Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Jan; Vol. 110 (1), pp. 422-431. Date of Electronic Publication: 2020 Oct 26.
Autor:
Prill S; DMPK, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Caddeo A; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Baselli G; Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Jamialahmadi O; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Dongiovanni P; Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Rametta R; Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Kanebratt KP; DMPK, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Pujia A; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy., Pingitore P; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Mancina RM; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden., Lindén D; Bioscience Diabetes, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.; Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Whatling C; Translational Sciences, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Janefeldt A; DMPK, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Kozyra M; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Ingelman-Sundberg M; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Valenti L; Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Andersson TB; DMPK, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Romeo S; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. stefano.romeo@wlab.gu.se.; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy. stefano.romeo@wlab.gu.se.; Cardiology Department, Sahlgrenska University Hospital, Gothenburg, Sweden. stefano.romeo@wlab.gu.se.
Publikováno v:
Scientific reports [Sci Rep] 2019 Aug 12; Vol. 9 (1), pp. 11585. Date of Electronic Publication: 2019 Aug 12.
Autor:
Prieto Garcia L; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.) luna.prietogarcia@astrazeneca.com., Janzén D; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.)., Kanebratt KP; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.)., Ericsson H; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.)., Lennernäs H; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.)., Lundahl A; Drug Metabolism and Pharmacokinetics; Cardiovascular, Renal and Metabolism (L.P.G., D.J., K.P.K., A.L.) and Quantitative Clinical Pharmacology; Early Clinical Development (H.E.), IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; and Department of Pharmacy, Uppsala University, Uppsala, Sweden (H.L.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2018 Oct; Vol. 46 (10), pp. 1420-1433. Date of Electronic Publication: 2018 Aug 01.
Autor:
Kvist AJ; IMED Operations Project Management, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Alexander.Kvist@astrazeneca.com., Kanebratt KP; Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Walentinsson A; Translational Sciences, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Palmgren H; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., O'Hara M; University Health Network, Toronto, Ontario, Canada., Björkbom A; Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Andersson LC; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Ahlqvist M; Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Andersson TB; Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2018 Sep; Vol. 155, pp. 124-140. Date of Electronic Publication: 2018 Jun 25.
Autor:
Lindmark B; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Lundahl A; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Kanebratt KP; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Andersson TB; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden., Isin EM; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2018 Jun; Vol. 175 (11), pp. 2116-2129. Date of Electronic Publication: 2018 Apr 19.
Autor:
Bauer S; TissUse GmbH, Berlin, Germany. sophie.bauer@tissuse.com., Wennberg Huldt C; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Kanebratt KP; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Durieux I; TissUse GmbH, Berlin, Germany., Gunne D; TissUse GmbH, Berlin, Germany., Andersson S; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Ewart L; Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Haynes WG; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Maschmeyer I; TissUse GmbH, Berlin, Germany., Winter A; TissUse GmbH, Berlin, Germany., Ämmälä C; Bioscience Diabetes, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Marx U; TissUse GmbH, Berlin, Germany., Andersson TB; DMPK, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Scientific reports [Sci Rep] 2018 Jan 23; Vol. 8 (1), pp. 1672. Date of Electronic Publication: 2018 Jan 23.